BioWorld

April 17, 2003

View Archived Issues

Primal Publishes GPCR Data, Comes Out Of 'Stealth Mode'

Read More

NimbleGen Completes $12.5M Round For Microarray Business

Read More

Other News To Note

Read More

U.S. Patent Disclosures

Read More

Genzyme Hits EPS Estimates, Reports Delay In Renagel Trial

Genzyme General's first-quarter revenue blossomed nicely and the company hit its earnings-per-share estimates, but the revelation of a data delay from a Renagel trial dropped the company's stock Wednesday. (BioWorld Today) Read More

GlycoFi Scientists Devise Genetic Combinatorial Library To Develop Humanized Glycosylation Displays

Read More